Ponatinib (Standard)
Ponatinib (Standard) is the analytical standard of Ponatinib. This product is intended for research and analytical applications. Ponatinib (AP24534) is an orally active multi-targeted kinase inhibitor with IC50s of 0.37 nM, 1.1 nM, 1.5 nM, 2.2 nM, and 5.4 nM for Abl, PDGFRα, VEGFR2, FGFR1, and Src, respectively[1].
Product Specifications
CAS Number
943319-70-8
Product Name Alternative
AP24534 (Standard)
UNSPSC
12352005
Target
Autophagy; Bcr-Abl; FGFR; PDGFR; Reference Standards; Src; VEGFR
Type
Reference Standards
Related Pathways
Autophagy; Others; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/ponatinib-standard.html
Smiles
CC1=C(C=C(C=C1)C(NC2=CC(C(F)(F)F)=C(C=C2)CN3CCN(CC3)C)=O)C#CC4=CN=C5N4N=CC=C5
Molecular Formula
C29H27F3N6O
Molecular Weight
532.56
References & Citations
[1]O'Hare T, et al. AP24534, a pan-BCR-ABL inhibitor for chronic myeloid leukemia, potently inhibits the T315I mutant and overcomes mutation-based resistance. Cancer Cell, 2009, 16 (5), 401-412.|[2]Gozgit JM, et al. Potent activity of ponatinib (AP24534) in models of FLT3-driven acute myeloid leukemia and other hematologic malignancies. Mol Cancer Ther, 2011, 10 (6), 1028-1035.|[3]Uchida T, et al. Hes1 upregulation contributes to the development of FIP1L1-PDGRA-positive leukemia in blast crisis. Exp Hematol. 2014 May;42 (5) :369-379.e3.
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
K2668903 1.0 µg DNA
ZDHHC7 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 034172-ML490 100 µL
CPNE8, NT (CPNE8, Copine-8, Copine VIII) (MaxLight 490) discontinued
Sign In for Pricing
View Details